EQUITY SECURITIES INFORMATION The Company has only one class of shares, being ordinary shares. Each ordinary share is entitled to one vote when a poll is called; otherwise on a show of hands at a shareholder meeting every member present in person or by proxy has one vote. There are no securities subject to escrow and there is no current on-market buy-back of securities. The following information is based on share registry information processed up to and including 24 March 2023. The number of ordinary shareholdings held in less than marketable parcels at 24 March 2023 was 381, holding 1,941 ordinary shares. DISTRIBUTION OF SECURITY HOLDERS Listed ordinary shares Size of holding Number of ordinary shares % Number of holders % 100,001 and Over 91,443,978 72.42 128 2.04 10,001 to 100,000 24,371,857 19.30 814 12.96 5,001 to 10,000 4,449,073 3.52 591 9.41 1,001 to 5,000 4,862,294 3.85 1,885 30.01 1 to 1,000 1,138,474 0.90 2,864 45.59 Total 126,265,676 100.00 6,282 100.00 UNLISTED SECURITIES 2,700,00 Loan Funded Shares, held as treasury stock, with a weighted average exercise price of $1.84, have an expiry date of 13 July 2025. There are 3 holders of 100,001 and over. 2,200,000 Employee Share Scheme options, with a weighted average exercise price of $3.59, of which 1,450,000 have an expiry date of 3 February 2026 and 750,000 have an expiry date of 8 July 2026. There are 5 holders of 100,001 and over. SUBSTANTIAL SECURITY HOLDERS The following have filed substantial holding notifications: Number held Percentage Milford Asset Management Limited 6,561,977 5.088% Substantial holdings are based on the last notice lodged on the ASX. ADD I T I ONA L I NFORMAT I ON CON T I NU E D Neuren Pharmaceuticals Limited Annual Repor t 2022 51
RkJQdWJsaXNoZXIy MjE2NDg3